New Analysis of UK Biobank Data on Plasminogen Levels Presented at International Society on Thrombosis and Haemostasis (ISTH) 2026

13 Jul, 2026 New Analysis of UK Biobank Data on Plasminogen Levels Presented at International Society on Thrombosis and Haemostasis (ISTH) 2026

In this analysis of UK Biobank data presented at ISTH, low plasminogen levels were not associated with an increased risk of myocardial infarction, ischaemic stroke, or arterial thrombosis. The findings support the continued development of ALN-6400—an investigational RNAi therapeutic targeting plasminogen—for the treatment of bleeding disorders.

Krohn, et al. “Low plasminogen levels are not associated with an increased risk of arterial thrombosis”